Mepivacaine 3% with levonordefrin approved for dental anesthesia in India

Mepivacaine hydrochloride 3% combined with levonordefrin indicated for infiltration and nerve-block anesthesia in dental procedures; rapid onset within 2–3 minutes and duration up to 120 minutes; approved by CDSCO in June 2024; available in 5 mL multi-dose vials across India; offers an alternative to lidocaine for longer-lasting pain control.